IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

EU fines six pharma firms for curbing entry of cheaper generic drugs

8:29 AM MDT | July 10, 2014 | Natasha Alperowicz

The European Commission announced on Wednesday that it has imposed fines totaling €427.7 million ($582.8 million) on the French pharmaceutical company Servier and five producers of generic drugs—Niche/Unichem; Matrix, now part of Mylan; Teva; Krka; and Lupin—for concluding a series of deals to protect Servier's best-selling blood pressure medicine, perindopril, from price competition by generics in the European Union. Through a technology acquisition and a series of patent settlements with generic rivals, Servier breached EU antitrust rules by...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa